135 related articles for article (PubMed ID: 36283390)
1. MYO10-filopodia support basement membranes at pre-invasive tumor boundaries.
Peuhu E; Jacquemet G; Scheele CLGJ; Isomursu A; Laisne MC; Koskinen LM; Paatero I; Thol K; Georgiadou M; Guzmán C; Koskinen S; Laiho A; Elo LL; Boström P; Hartiala P; van Rheenen J; Ivaska J
Dev Cell; 2022 Oct; 57(20):2350-2364.e7. PubMed ID: 36283390
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.
Arjonen A; Kaukonen R; Mattila E; Rouhi P; Högnäs G; Sihto H; Miller BW; Morton JP; Bucher E; Taimen P; Virtakoivu R; Cao Y; Sansom OJ; Joensuu H; Ivaska J
J Clin Invest; 2014 Mar; 124(3):1069-82. PubMed ID: 24487586
[TBL] [Abstract][Full Text] [Related]
3. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
[TBL] [Abstract][Full Text] [Related]
4. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
[TBL] [Abstract][Full Text] [Related]
5. Myosin-X and talin modulate integrin activity at filopodia tips.
Miihkinen M; Grönloh MLB; Popović A; Vihinen H; Jokitalo E; Goult BT; Ivaska J; Jacquemet G
Cell Rep; 2021 Sep; 36(11):109716. PubMed ID: 34525374
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
7. SMARCE1 is required for the invasive progression of in situ cancers.
Sokol ES; Feng YX; Jin DX; Tizabi MD; Miller DH; Cohen MA; Sanduja S; Reinhardt F; Pandey J; Superville DA; Jaenisch R; Gupta PB
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4153-4158. PubMed ID: 28377514
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis.
Cao R; Chen J; Zhang X; Zhai Y; Qing X; Xing W; Zhang L; Malik YS; Yu H; Zhu X
Br J Cancer; 2014 Jul; 111(3):539-50. PubMed ID: 24921915
[TBL] [Abstract][Full Text] [Related]
9. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
10. TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
12. PtdIns(3,4,5)P₃ is a regulator of myosin-X localization and filopodia formation.
Plantard L; Arjonen A; Lock JG; Nurani G; Ivaska J; Strömblad S
J Cell Sci; 2010 Oct; 123(Pt 20):3525-34. PubMed ID: 20930142
[TBL] [Abstract][Full Text] [Related]
13. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
[TBL] [Abstract][Full Text] [Related]
14. Myosin-X is a molecular motor that functions in filopodia formation.
Bohil AB; Robertson BW; Cheney RE
Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12411-6. PubMed ID: 16894163
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
16. Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS.
Visser LL; Elshof LE; Van de Vijver K; Groen EJ; Almekinders MM; Sanders J; Bierman C; Peters D; Hofland I; Broeks A; van Leeuwen FE; Rutgers EJT; Schmidt MK; Schaapveld M; Lips EH; Wesseling J
Am J Surg Pathol; 2019 Nov; 43(11):1574-1582. PubMed ID: 31206365
[TBL] [Abstract][Full Text] [Related]
17. Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
Bergholtz H; Kumar S; Wärnberg F; Lüders T; Kristensen V; Sørlie T
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1248. PubMed ID: 32671987
[TBL] [Abstract][Full Text] [Related]
18. Everolimus Inhibits the Progression of Ductal Carcinoma
Chen G; Ding XF; Pressley K; Bouamar H; Wang B; Zheng G; Broome LE; Nazarullah A; Brenner AJ; Kaklamani V; Jatoi I; Sun LZ
Clin Cancer Res; 2020 Mar; 26(6):1486-1496. PubMed ID: 31871301
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
